Affymetrix CytoScan Dx Assay for postnatal detection of DNA CNVs

Wednesday, 16 April, 2014 | Supplied by: Millennium Science Pty Ltd


The Affymetrix CytoScan Dx Assay is intended for the postnatal detection of DNA copy number variants (CNV) in patients referred for chromosomal testing. It is designed to help physicians diagnose children’s developmental and intellectual disabilities more comprehensively by enabling a high-resolution genome-wide analysis of genetic aberrations.

The product analyses the whole genome in a single assay at very good resolution, improving diagnostic capability. High-resolution analysis can reveal small aberrations not readily seen using traditional techniques.

The company’s For Research Use Only version of the assay is currently available in Australia for both constitutional and cancer cytogenetics research applications.

Online: www.mscience.com.au
Phone: 1800 678 242
Related Products

Lonza 4D-Nucleofector LV Unit PRO electroporation unit

Lonza's 4D-Nucleofector LV Unit PRO is a next-generation, large-scale electroporation unit...

Cytek 25-Color Immunoprofiling Assay, cFluor Reagent Kit (18C)

The Cytek 25-Color Immunoprofiling Assay has been designed and optimised to provide a turnkey...

Bio-Rad Laboratories QX Continuum and QX700 series ddPCR platforms

The latest platforms complement Bio-Rad's existing QX ddPCR portfolio and offer users...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd